Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension (Q48015206)

7 February 2018

title

Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension (English)

1 reference

7 February 2018

main subject

arterial hypertension

0 references

Peter W de Leeuw

1 reference

7 February 2018

Ingrid J M Scheffers

1 reference

7 February 2018

Abraham A Kroon

series ordinal

1 reference

7 February 2018

Jan H M Tordoir

series ordinal

1 reference

7 February 2018

publication date

1 January 2008

1 reference

7 February 2018

Expert Review of Medical Devices

published in

1 reference

7 February 2018

volume

1 reference

7 February 2018

issue

1 reference

7 February 2018

page(s)

33-39

1 reference

7 February 2018

High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Sympathetic activation in the pathogenesis of hypertension and progression of organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

The sympathetic system and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Relationship between central sympathetic activity and stages of human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

The changing face of sympathetic overactivity in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Neurogenic hypertension: is the enigma of its origin near the solution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Counteracting the sympathetic nervous system in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Pharmacoeconomic burden of undertreating hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Prolonged activation of the baroreflex produces sustained hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.5.1.33

21 January 2018

Identifiers

DOI

10.1586/17434440.5.1.33

1 reference

7 February 2018

release_ehyk6tlesrfm7feup6jrbpix2u

Fatcat ID

0 references

1 reference

7 February 2018